BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 1758440)

  • 21. Effects of imidazole compounds on catecholamine release in adrenal chromaffin cells.
    Ohara-Imaizumi M; Kumakura K
    Cell Mol Neurobiol; 1992 Jun; 12(3):273-83. PubMed ID: 1330311
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Alpha 2-adrenoceptors do not regulate catecholamine secretion by bovine adrenal medullary cells: a study with clonidine.
    Powis DA; Baker PF
    Mol Pharmacol; 1986 Feb; 29(2):134-41. PubMed ID: 2869403
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The role of imidazoline receptors in blood pressure regulation.
    Hamilton CA
    Pharmacol Ther; 1992; 54(3):231-48. PubMed ID: 1361236
    [TBL] [Abstract][Full Text] [Related]  

  • 24. An endogenous clonidine-displacing substance from bovine brain: receptor binding and hypotensive actions in the ventrolateral medulla.
    Meeley MP; Ernsberger PR; Granata AR; Reis DJ
    Life Sci; 1986 Mar; 38(12):1119-26. PubMed ID: 3007903
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Agmatine--a novel endogenous ligand of imidazoline receptors.
    Herman ZS
    Pol J Pharmacol; 1997; 49(2-3):85-8. PubMed ID: 9437754
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The brain's own clonidine: purification and characterization of endogenous clonidine displacing substance from brain.
    Atlas D; Diamant S; Fales HM; Pannell L
    J Cardiovasc Pharmacol; 1987; 10 Suppl 12():S122-7. PubMed ID: 2455163
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The effects of imidazoline agents on the aggregation of human platelets.
    Pinthong D; Songsermsakul P; Rattanachamnong P; Kendall DA
    J Pharm Pharmacol; 2004 Feb; 56(2):213-20. PubMed ID: 15005880
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Adrenal medulla calcium channel population is not conserved in bovine chromaffin cells in culture.
    Benavides A; Calvo S; Tornero D; González-García C; Ceña V
    Neuroscience; 2004; 128(1):99-109. PubMed ID: 15450357
    [TBL] [Abstract][Full Text] [Related]  

  • 29. An antiserum to idazoxan recognizes an immunoreactive substance in human serum and cerebral spinal fluid which is not agmatine.
    Wang H; Regunathan S; McGowan D; Bramwell S; Reis DJ
    Neurochem Int; 1997 Jan; 30(1):85-94. PubMed ID: 9116591
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Suppressed renal response to 2,6-dimethyl clonidine but not clonidine in one kidney-one clip hypertensive rats.
    Li P; Smyth DD
    J Pharmacol Exp Ther; 1993 Dec; 267(3):1395-400. PubMed ID: 7903388
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Characterization of imidazoline binding protein(s) solubilized from human brainstem: studies with [3H]idazoxan and [3H]clonidine.
    Greney H; Bricca G; Dontenwill M; Stutzmann J; Bousquet P; Belcourt A
    Neurochem Int; 1994 Aug; 25(2):183-91. PubMed ID: 7994199
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Heterogeneity of the specific imidazoline binding of [3H]idazoxan in the human cerebral cortex.
    Bricca G; Greney H; Dontenwill-Kieffer M; Zhang J; Belcourt A; Bousquet P
    Neurochem Int; 1993 Feb; 22(2):153-63. PubMed ID: 8439769
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Heterogeneity of imidazoline binding sites revealed by a cirazoline derivative.
    Greney H; Molines A; Bousquet P; Dontenwill M
    Eur J Pharmacol; 1994 Dec; 271(2-3):533-6. PubMed ID: 7705454
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Is imidazoline site a unique receptor? A correlation with clonidine-displacing substance activity.
    Atlas D; Diamant S; Zonnenschein R
    Am J Hypertens; 1992 Apr; 5(4 Pt 2):83S-90S. PubMed ID: 1317715
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evidence for the presence of a non-catecholamine, clonidine-displacing substance in crude, methanolic extracts of bovine brain and lung.
    Singh G; Hussain JF; MacKinnon A; Brown CM; Kendall DA; Wilson VG
    Naunyn Schmiedebergs Arch Pharmacol; 1995 Jan; 351(1):17-26. PubMed ID: 7715736
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of clonidine and other imidazole-receptor binding agents on second messenger systems and calcium influx in bovine adrenal chromaffin cells.
    Regunathan S; Evinger MJ; Meeley MP; Reis DJ
    Biochem Pharmacol; 1991 Oct; 42(10):2011-8. PubMed ID: 1660273
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Blockade by agmatine of catecholamine release from chromaffin cells is unrelated to imidazoline receptors.
    Santos WC; Hernández-Guijo JM; Ruiz-Nuño A; Olivares R; Jurkiewicz A; Gandía L; García AG
    Eur J Pharmacol; 2001 Apr; 417(1-2):99-109. PubMed ID: 11301064
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Identification of human I1 receptors and their relationship to alpha 2-adrenoceptors.
    Dontenwill M; Vonthron C; Greney H; Magnier C; Heemskerk F; Bousquet P
    Ann N Y Acad Sci; 1999 Jun; 881():123-34. PubMed ID: 10415908
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Binding of [3H]clonidine to I1-imidazoline sites in bovine adrenal medullary membranes.
    Molderings GJ; Moura D; Fink K; Bönisch H; Göthert M
    Naunyn Schmiedebergs Arch Pharmacol; 1993 Jul; 348(1):70-6. PubMed ID: 8377842
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Human brain imidazoline receptors: further characterization with [3H]clonidine.
    Bricca G; Greney H; Zhang J; Dontenwill M; Stutzmann J; Belcourt A; Bousquet P
    Eur J Pharmacol; 1994 Jan; 266(1):25-33. PubMed ID: 8137880
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.